Acyclovir is also known as acyclovir (ACV). It is an antiviral medication. It is mainly used for the cure of shingles, herpes simplex virus, and chickenpox. Other uses comprise infections by Epstein –Barr virus and prevention of cytomegalovirus.
Common side effects are diarrhea and nausea. Potentially side effects encompass low platelets and kidney problems.
Those with poor kidney or live function needs better care. Its consumption is safe during pregnancy as no harm has been observed. It also comes safe during pregnancy. Acyclovir was derived in 1977. WHO stated that it is one of the most important medication needed in the human body. It can be accessible as a generic medication, thus, impacting the acyclovir industry demand.
It is medically used in neonatal herpes simplex, herpes simplex encephalitis, genital herpes simplex, herpes of the eyes, and others. Acyclovir, when taken orally, could not reduce the hazard of the pain of shingles.
View Full Report with TOC @ http://www.radiantinsights.com/research/global-and-chinese-acyclovir-industry-2015-market-research-report
Acyclovir has adverse effects in systemic and topical therapy. In systemic therapy, common adverse drug reaction comprises encephalopathy, nausea, vomiting, and headache. Intravenous acyclovir may result into reversible nephrotoxicity.
Acyclovir crystalline nephropathy is more widespread when acyclovir is known as a brisk combination and in patients with dehydration and preexisting renal mutilation. Adequate hydration, a slower pace of combination, and dosing on the basis of renal purpose might decrease this threat. Acyclovir topical cream is usually related (≥1% of patients) with dry or peeling skin or transient stinging/burning feelings. Uncommon unfavorable effects consist of erythema or itch.
The global acyclovir industry is expanding at a significant pace in the coming years. The market can be further evaluated by production value/product specifications and capacity. Evaluation is also done by downstream dynamics, raw materials, market trends, and competitive landscapes.
Related reports by Radiant Insights: http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
Acyclovir could be quantitated in serum or plasma to observe for drug buildup in patients with renal dysfunction or to verify a diagnosis of poisoning insensitive overdose patients.
Acyclovir is inadequately water-soluble and has deprived oral bioavailability (15–30%), therefore intravenous management is essential if high concentrations are necessary. When orally administered, maximum plasma concentration happens after 1–2 hours.
Table of Contents
Chapter One Introduction of Acyclovir Industry
1.1 Brief Introduction of Acyclovir
1.2 Development of Acyclovir Industry
1.3 Status of Acyclovir Industry
Chapter Two Manufacturing Technology of Acyclovir
2.1 Development of Acyclovir Manufacturing Technology
2.2 Analysis of Acyclovir Manufacturing Technology
2.3 Trends of Acyclovir Manufacturing Technology
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com
No comments:
Post a Comment